HCA Healthcare Inc. (NYSE: HCA) announced that its subsidiary HCA Inc. proposes to offer senior notes, subject to market and other considerations. The company stated that actual terms including maturity, interest rate and principal amount will depend on market conditions at the time of pricing.

HCA Inc. plans to use net proceeds for general corporate purposes, which may include repaying outstanding borrowings under its $4.000 billion commercial paper program. The company may also use a portion of proceeds to redeem all or part of $1.500 billion in 5.250% senior notes due June 2026 and $1.000 billion in 5.375% senior notes due September 2026.

Citigroup Global Markets Inc., Barclays Capital Inc., BofA Securities Inc., and J.P. Morgan Securities LLC are serving as joint book-running managers for the offering.

The offering is being made pursuant to an effective shelf registration statement filed with the Securities and Exchange Commission. The company noted that prospectus supplements and accompanying prospectuses are available through the underwriters and the SEC website.

The press release specified that it does not constitute an offer to sell or solicitation to buy the senior notes, and any redemption notices for existing notes will be issued separately.